These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Ketoconazole in the treatment of chronic mucocutaneous candidiasis secondary to autoimmune polyendocrinopathy-candidiasis syndrome. Appleboom TM; Flowers FP Cutis; 1982 Jul; 30(1):71-2. PubMed ID: 6288325 [No Abstract] [Full Text] [Related]
12. Ketoconazole in a case of chronic mucocutaneous candidiasis. Zachariae H; Laurberg G; Thestrup-Pedersen K Acta Derm Venereol; 1982; 62(1):87-9. PubMed ID: 6175153 [TBL] [Abstract][Full Text] [Related]
13. The treatment of patients with chronic mucocutaneous candidosis and candida onychomycosis with ketoconazole. Hay RJ; Clayton YM Clin Exp Dermatol; 1982 Mar; 7(2):155-62. PubMed ID: 6282505 [No Abstract] [Full Text] [Related]
14. Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis. Roberton DM; Hosking CS Aust Paediatr J; 1983 Sep; 19(3):178-81. PubMed ID: 6316890 [TBL] [Abstract][Full Text] [Related]
15. Systemic treatment of skin candidosis: a randomized comparison of terbinafine and ketoconazole. Jung EG; Haas PJ; Bräutigam M; Weidinger G Mycoses; 1994; 37(9-10):361-5. PubMed ID: 7746297 [TBL] [Abstract][Full Text] [Related]
20. Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. Smith DE; Midgley J; Allan M; Connolly GM; Gazzard BG AIDS; 1991 Nov; 5(11):1367-71. PubMed ID: 1662959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]